FFCP PHASE1:Mm9::chr5:92691818..92691825,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=67111|HGNC=|MCL_coexpression_id=106|UniProt=|association_with_transcript=-10bp_to_ENSMUST00000159732,uc008ycp.2_5end|description=CAGE_peak_13_at_Naaa_5end|id=chr5:92691818..92691825,-|ontology_enrichment_celltype=CL:0000006!1.74e-08!1;CL:0002374!1.74e-08!1;CL:0000202!1.74e-08!1;CL:0000199!1.74e-08!1;CL:0000855!1.74e-08!1;CL:0000589!1.74e-08!1|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0005795!8.44e-18!4;UBERON:0000995!8.44e-18!4;UBERON:0003134!1.55e-15!8;UBERON:0003975!2.27e-14!5;UBERON:0000474!7.61e-14!9;UBERON:0003100!2.22e-11!11;UBERON:0006834!4.39e-09!1;UBERON:0004175!3.11e-08!9|ontology_enrichment_uberon_v019_2=UBERON:0006834,2.74e-44,1;UBERON:0005795,4.54e-44,4;UBERON:0000995,4.54e-44,4;UBERON:0003975,1.42e-35,5;UBERON:0003134,8.41e-23,8;UBERON:0004175,1.98e-20,9;UBERON:0000474,1.98e-20,9;UBERON:0003100,5.67e-17,11;UBERON:0003133,1.75e-08,24;UBERON:0005156,6.33e-08,26;UBERON:0000990,6.33e-08,26|phase1_expression=0.160148847104794,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11418387971906,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.284163499395593,0,0,0,0,0,0,0,0,0,0,0,0.0810688095458557,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.283880170416537,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.23467170806371,0,0,0,0.161464426695906,0,0.119372344003136,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.00583921443782,1.09890974560359,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.188626341386076,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.214871054048298,0,0,0|short_description=p13@Naaa}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=entrezgene:67111 | |||
|HGNC= | |||
|MCL_coexpression_id=106 | |||
|TSSclassifier=NA | |||
|UniProt= | |||
|association_with_transcript=-10bp_to_ENSMUST00000159732,uc008ycp.2_5end | |||
|cluster_id=chr5:92691818..92691825,- | |||
|description=CAGE_peak_13_at_Naaa_5end | |||
|id=chr5:92691818..92691825,- | |||
|ontology_enrichment_celltype=CL:0000006!1.74e-08!1;CL:0002374!1.74e-08!1;CL:0000202!1.74e-08!1;CL:0000199!1.74e-08!1;CL:0000855!1.74e-08!1;CL:0000589!1.74e-08!1 | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0005795!8.44e-18!4;UBERON:0000995!8.44e-18!4;UBERON:0003134!1.55e-15!8;UBERON:0003975!2.27e-14!5;UBERON:0000474!7.61e-14!9;UBERON:0003100!2.22e-11!11;UBERON:0006834!4.39e-09!1;UBERON:0004175!3.11e-08!9 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0006834,2.74e-44,1;UBERON:0005795,4.54e-44,4;UBERON:0000995,4.54e-44,4;UBERON:0003975,1.42e-35,5;UBERON:0003134,8.41e-23,8;UBERON:0004175,1.98e-20,9;UBERON:0000474,1.98e-20,9;UBERON:0003100,5.67e-17,11;UBERON:0003133,1.75e-08,24;UBERON:0005156,6.33e-08,26;UBERON:0000990,6.33e-08,26 | |||
|phase1_expression=0.160148847104794,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11418387971906,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.284163499395593,0,0,0,0,0,0,0,0,0,0,0,0.0810688095458557,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.283880170416537,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.23467170806371,0,0,0,0.161464426695906,0,0.119372344003136,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.00583921443782,1.09890974560359,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.188626341386076,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.214871054048298,0,0,0 | |||
|short_description=p13@Naaa | |||
}} |
Revision as of 19:15, 4 August 2015
Short description: | p13@Naaa |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_13_at_Naaa_5end |
Coexpression cluster: | MCL_coexpression_mm9:106 |
Association with transcript: | -10bp_to_ENSMUST00000159732, uc008ycp.2_5end |
EntrezGene: | 67111 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
uterus or analog | 2.74e-44 | 1 |
embryonic uterus | 4.54e-44 | 4 |
uterus | 4.54e-44 | 4 |
internal female genitalia | 1.42e-35 | 5 |
female reproductive organ | 8.41e-23 | 8 |
internal genitalia | 1.98e-20 | 9 |
female reproductive system | 1.98e-20 | 9 |
female organism | 5.67e-17 | 11 |
reproductive organ | 1.75e-08 | 24 |
reproductive structure | 6.33e-08 | 26 |
reproductive system | 6.33e-08 | 26 |